9 C
New York
Monday, December 4, 2023

Procept BioRobotics Corp (NASDAQ: PRCT) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Procept BioRobotics Corp (PRCT) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.04, or 0.12%, to $32.65. The Procept BioRobotics Corp has recorded 27,302 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

Procept BioRobotics Corp is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. At the end of the last regular session, the stock closed at $32.61 and fluctuated between $32.65 as its day high and $27.65 as its day low. The current market capitalization of Procept BioRobotics Corp is $1.48B. A total of 1.37 million shares were traded on the day, compared to an average of 452.90K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, PRCT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 17 BUYs and 23 SELLs from insiders. Insiders purchased 231,202 shares during that period but sold 3,622,116.

In the most recent transaction, Nouri Alaleh sold 7,903 shares of PRCT for 40.00 per share on Jul 27. After the transaction, the EVP, CLO, CORP. SEC. now owns 46,933 company shares. In a previous transaction on Jun 15, Waters Kevin sold 22,631 shares at 35.12 per share. PRCT shares that EVP, CFO owns now total 33,523.

Among the insiders who sold shares, Shiblaq Hisham disposed of 21,930 shares on Apr 11 at a per-share price of $35.23. This resulted in the EVP, Chief Comm. Officer holding 31,414 shares of PRCT after the transaction. In another insider transaction, Zadno Reza sold 5,335 shares at $31.84 per share on Mar 16. Company shares held by the President, CEO now total 155,791.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for PRCT in the last 3 months, the mean price target is $43.00 with high estimates of $55.00 and low estimates of $37.00. In terms of 52-week highs and lows, PRCT has a high of $47.75 and a low of $24.83.

As of this writing, PRCT has an earnings estimate of -$0.53 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.51 per share and a lower estimate of -$0.56. The company reported an EPS of -$0.63 in the last quarter, which was -8.60% lower than expectations of -$0.58.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PRCT’s latest balance sheet shows that the firm has $304.32M in Cash & Short Term Investments as of fiscal 2021. There were $54.10M in debt and $16.24M in liabilities at the time. Its Book Value Per Share was $3.44, while its Total Shareholder’s Equity was $267.09M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PRCT is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles